Inovio Pharmaceuticals, Inc.NASDAQ: INO

INOVIO to Participate in Upcoming Investor Conferences

· Issued by Inovio Pharmaceuticals, Inc. via PR Newswire

Summary by 6ix AI

INOVIO, a biotechnology company developing DNA medicines for HPV-related diseases (HPV is human papillomavirus), cancer and infectious diseases, will take part in the Cantor Global Healthcare Conference in New York and the H.C. Wainwright 28th Annual Global Investment Conference in New York, where its presentation will be virtual.

Key details

  • At the Cantor Global Healthcare Conference, INOVIO will hold a fireside chat on Wednesday, September 9 at 3:20 PM ET, with a webcast.
  • For the H.C. Wainwright 28th Annual Global Investment Conference, INOVIO's virtual presentation will be available beginning Friday, September 11, 7:00 AM ET.
  • Replays of the investor presentations will be available for 90 days, and members of INOVIO's management team will also hold one-on-one meetings with investors during the conferences.

6ix AI wrote this summary from the release below and checked it against the release.

PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:

Cantor Global Healthcare Conference (New York)
Date: Wednesday, September 9
Fireside Chat: 3:20 PM ET
Webcast: https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=99315971&checkCompany=1&checkEmail=1&checkName=1

H.C. Wainwright 28th Annual Global Investment Conference (New York)
Presentation Available: Beginning Friday, September 11, 7:00 AM ET
Format: Virtual
Link: https://journey.ct.events/view/eb47953c-3213-432d-92ca-13beb55c97ae

Replays of the investor presentations will be available for 90 days at the links above. During these conferences members of INOVIO's management team will also be conducting one-on-one meetings with investors.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-302866521.html

SOURCE INOVIO Pharmaceuticals, Inc.

View original source (PR Newswire)Inovio Pharmaceuticals, Inc. on 6ix

Story so far

Earlier from Inovio Pharmaceuticals

Later from Inovio Pharmaceuticals

All Inovio Pharmaceuticals news releases